Genome & Company

Genome & Company


Genome & Company
B-8F Silicon Park, 35 Pangyo-ro 255beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea, 13486


Consent to collection and use of personal information (Required)

Genome & Company (the ”Company”) regards the protection of personal information of our users very important, and complies with relevant laws, including the Personal Information Protection Act and the Act on Expansion of Dissemination and Promotion of Utilization of Information System. The Company hereby informs the purpose and method of using the personal information provided by our users through the Company’s website, and what measures are taken to protect the personal information. If the Company revises any of this Private Policy, it will be notified through the notices on the Company’s website (or individually notified).

1. Items of Personal Information Collected and the Collection Method

The Company collects the following personal information to operate its Contact Service via the Company’s website (whereby the users can make general inquires, inquiry for business development, IR inquiry, media inquiry, etc.).
- Essential Information: name, e-mail address, phone number, organization, content of inquiry
- Collection method: The Company collects the personal information through the inquiries submitted via the Contact Bulletin Board on the Company’s website.

  You have the right to refuse the ‘collection of essential information’ as well as the ‘collection of optional information’. If you refuse the collection of essential information, however, you may be restricted for using the Contact Service.

The following information may be automatically generated and collected in the process of using the website.
- IP Address, cookie, date and time of visit, records of service use

2. Purpose of Collecting Personal Information

The Company uses the collected personal information for the following purposes.
- Personal verification, personal identification, delivery of inquiries and notification of results (answers and responses), etc. related to the use of Contact Service

3. Processing of Personal Information and Retention Period

In principle, the collected personal information is destroyed without any delay after achieving the purpose of collecting and using personal information. However, the Company may keep users’ information for a certain period of time as required by relevant laws.
- Retained information: personal information submitted with the inquiry, content of the inquiry, and ensuing responses
- Relevant Law: Act on the Consumer Protection in Electronic Commerce, etc.
- Retention Period: three years (records related to resolution of consumer complaints or disputes)

4. Destruction of Personal Informatio

In principle, the information is destroyed without any delay after achieving the purpose of collecting and using personal information. The procedure and method of destruction are as follows.

1) Procedure
The personal information submitted is transferred to a separate database (in case of paper, separate cabinet) after achieving the purpose and kept for a certain period of time according to the internal policy and other relevant laws, before it is destroyed. The personal information transferred to separate database shall not be used any other purposes other than for keeping in accordance with laws.

  2) Destruction Method
Personal information saved in the form of electronic file shall be deleted by using technical method that cannot reproduce the records. Personal information printed in the paper shall be destroyed by shredding with a shredder or incinerating it.

5. Consignment of Personal Information Processing

The Company does not consign personal information to a third party. If consignment occurs in the future, it shall be notified through website and the contents of this Privacy Policy shall be updated.

6. Rights of Users and Their Legal Representatives

Users and their legal representative (for the users below the age of 14) may make an inquiry related to or request deletion or modification of their own personal information. In this case, please contact the Company’s Data Protection Manager (see Section 7 of this Privacy Policy) in writing, by phone, or by e-mail so that we can take measures without any delay after verifying your identification.

In case users request the correction of any errors in personal information, we shall not use or provide the personal information until such correction is made. In addition, in case incorrect personal information is already provided to a third party, we will notify the third party the result of correction without delay.

The Company processes and destroys personal information at the request of users or their legal representatives in accordance with Section ‘3. Processing of Personal Information and Retention Period’ and Section ‘4. Destruction of Personal Information’, and such information shall not be opened or used for any other purposes.

7. Information on Data Protection Officer and Manager

The Company designates data protection officer and manager for managing personal information as follows to protect users’ personal information related to inquiries.

Data Protection Officer
Name: Seo Yeong-jin
Department: Business management
Position: Vice-president
Telephone: 031-620-0150

  Data Protection Manager
Name: Seol Su-gi
Department: PR team
Position: Team Lead
Telephone: 070-4821-3840

You can submit to the personnel above any inquiries related to your personal information submitted to the Company while using our web service. The Company will quickly provide sufficient responses to your inquiries.

Please contact the below agencies if you need report or counseling for any infringement of personal data privacy.

- Personal Information Infringement Report Center ( / 118 without area code)
- Personal Information Dispute Mediation Committee ( / 1833-6972)
- Cyber Investigation Department, Supreme Prosecutor’s Office ( / 1301 without area code)
- Cyber Bureau of the National Police Agency ( / 182 without area code)

8. Notification

We will notify users any additions, deletions, and modification on the current Privacy Policy in advance through ‘Notice’ on the Company’s website.

9. Other Websites

We inform you that any collection of personal information by other websites which may be hyperlinked on the Company’s website is not the subject of this Privacy Policy.

Press Release

[Press Release] Genome & Company wins Red Dot Design Award 2021


Genome & Company wins Red Dot Design Award 2021


n  Awarded for excellence in design quality of new corporate identity, after first released in May 2021

n  Evaluated creative brand communication with new design motif and color system,
that attempts to break from the conventional image of the biotech industry


[August 23, 2021] A global immune-oncology biotech, Genome & Company (314130, CEO: Jisoo Pae ∙ Hansoo Park) has won the Red Dot Award: Brand & Communications 2021, one of the world largest design awards. The award recognized the quality of company’s brand identity and graphic motif design. 


The logo and graphic motif of Genome & Company use vibrant colors that represent major business areas: microbiome and antibody drug research and development, thus differentiates itself from other biotech companies by communicating creativity and friendliness through its designs. To accentuate the slogan ‘Dare to Achieve’, bold brushstrokes were placed to convey the daring challenges of Genome & Company that will achieve breakthrough innovation to fruition.


Founded in 1955, Red Dot Design Award is one of the three most renown global design competitions along with iF Design Award and IDEA (International Design Excellence Awards). Every year, companies worldwide submit their works, and winners are evaluated and announced in three disciplines: Product Design, Brands & Communication, and Design Concept. Genome & Company won the Red Dot Awards: Brands & Communications is a relatively new division established in 1993, announces winners from various categories including corporate design & identity, advertising, sound design and interactive media.


“We are glad that our attempt to break from the conventional image of biotech companies in the design field has led to the winning of a global design award.” Jisoo Pae, CEO of Genome & Company also stated, “We hope that our design system can communicate to the world our vision to ensure all people’s right to health.”


Established in 2015, Genome & Company is a Korean biotechnology company where its R&D program focuses on oncology microbiome, novel target immune-oncology therapeutics and consumer products. Genome & Company continues its R&D activities investigating next waves of innovative new drugs to overcome the unmet medical needs of cancer patients who lacked alternative therapeutic options other than cytotoxic chemotherapy (CTX) and molecular target therapy (MTT)



# # #

[Image 1] Award entry image of Red Dot Award: Brands & Communication Design

About Genome & Company

Since its establishment in 2015, Genome & Company develops next waves of innovative drugs including anti-cancer microbiome therapeutics and novel target immune checkpoint inhibitors. With the acquisition of Scioto Biosciences, a US biotech, in August 2020, the company has expanded its global microbiome pipeline into brain diseases and continues to pioneer the market to transform into a global microbiome healthcare group capable of research, development and production. For more information, please refer to our website


# # #


PREV [Press Release] Genome & Company establishes affiliate List Bio in the U.S. and constructs a large-scale microbiome manufacturing facility in Fishers
NEXT [Press Release] Scioto Biosciences, Inc announces first patient dosed in Phase Ib study in patients diagnosed with Autistic Disorder